Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Human Microbiome Market Size study, by Product (Probiotics, Prebiotics, Foods, Medical Foods, Diagnostic Tests and Drugs), By Application (Therapeutics and Diagnostics), By Disease (Infectious Diseases, Inflammatory Diseases, Endocrine & Metabolic Disorders, Cancer and Other Diseases), By Technology (Genomics, Proteomics and Metabolomics) and Regional Forecasts 2019-2026

  • BIZ3355134
  • 200 Pages
  • November 2019
  • Healthcare
Download Sample    Get Discount   
 
Global Human Microbiome Market is valued approximately at USD 291.08 million in 2018 and is anticipated to grow with a healthy growth rate of more than 25% over the forecast period 2019-2026. Human microbiome can be defined as the aggregate of all microbiota which resides on or inside human tissues and biofluids coupled with the corresponding anatomical sites in which they reside, comprising the skin, uterus, mammary glands, conjunctiva, ovarian follicles, biliary tract, placenta, seminal fluid, lung, saliva, oral mucosa, and gastrointestinal tract. Human microbiome consists of bacteria, fungi, viruses, protists and archaea. Also, a human body harbors microorganism having a ratio of 3:1 as contrasted to the number of human cells present. The relationship of most microbes with the human bodies varies from being mutualistic and commensal to neutral and harmful. Rising incidences of chronic diseases such as cancer, crohn’s syndrome and bowel syndrome along with advancements in the field of microscopic research on human health are the few factors responsible for high CAGR of the market over the forecast period. For instance, In 2018, it was estimated that there were 9.5 million cancer deaths and 17.0 million new cancer cases worldwide. The global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to the growth and aging of the population, according to the International Agency for Research on Cancer (IARC). Thus, the prevalence of chronic disease is on surging trend across the globe thereby, the need for human microbiome is also increased as it is proved as effective to defend the chronic diseases as well as facilitates a healthy immune system through which the market is growing at significant rate. Moreover, investigational new drug requirements for fecal microbiota aided with growing number of collaborations among market players is the major factor likely to offer lucrative growth opportunity to the market in the upcoming years. However, a lack of expertise as well as barriers in proving the causal link between dysbiosis and diseases are few factors anticipated to hampering the growth of global Smart Water Metering market during the forecast period.

The regional analysis of global Human Microbiome Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world as well as anticipated to exhibit at highest growth rate / CAGR over the forecast period 2019-2026. Factors such as the increasing prevalence of chronic diseases, rising awareness among people on preventive healthcare, high availability of funding for microbiome research, and rising acceptance of probiotic products thereby, impelling the demand for human microbiome across the world.

Major market player included in this report are:

Enterome Bioscience

Seres Therapeutics

4D Pharma PLC

Ubiome, Inc.

E.I. Du Pont De Nemours and Company

Synlogic

Second Genome

Vedanta Biosciences, Inc.

Ferring Pharmaceuticals

Evelo Biosciences, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Probiotics

Prebiotics

Foods

Medical Foods

Diagnostic Tests

Drugs

By Application:

Therapeutics

Diagnostics

By Disease:

Infectious Diseases

Inflammatory Diseases

Endocrine & Metabolic Disorders

Cancer

Other Diseases

By Technology:

Genomics

Proteomics

Metabolomics

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017

Base year – 2018

Forecast period – 2019 to 2026

Target Audience of the Global Human Microbiome Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)

1.2.1. Human Microbiome Market, by Product, 2017-2026 (USD Million)

1.2.2. Human Microbiome Market, by Application, 2017-2026 (USD Million)

1.2.3. Human Microbiome Market, by Disease, 2017-2026 (USD Million)

1.2.4. Human Microbiome Market, by Technology, 2017-2026 (USD Million)

1.2.5. Human Microbiome Market, by Region, 2017-2026 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Human Microbiome Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Type Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Human Microbiome Market Dynamics

3.1. Human Microbiome Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Human Microbiome Market Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Human Microbiome Market, by Product

5.1. Market Snapshot

5.2. Global Human Microbiome Market by Product, Performance - Potential Analysis

5.3. Global Human Microbiome Market Estimates & Forecasts by Product 2016-2026 (USD Million)

5.4. Human Microbiome Market, Sub Segment Analysis

5.4.1. Probiotics

5.4.2. Prebiotics

5.4.3. Foods

5.4.4. Medical Foods

5.4.5. Diagnostic Tests

5.4.6. Drugs

Chapter 6. Global Human Microbiome Market, by Application

6.1. Market Snapshot

6.2. Global Human Microbiome Market by Type, Performance - Potential Analysis

6.3. Global Human Microbiome Market Estimates & Forecasts by Type 2016-2026 (USD Million)

6.4. Human Microbiome Market, Sub Segment Analysis

6.4.1. Therapeutics

6.4.2. Diagnostics

Chapter 7. Global Human Microbiome Market, by Disease

7.1. Market Snapshot

7.2. Global Human Microbiome Market by Disease, Performance - Potential Analysis

7.3. Global Human Microbiome Market Estimates & Forecasts by Disease 2016-2026 (USD Million)

7.4. Human Microbiome Market, Sub Segment Analysis

7.4.1. Infectious Diseases

7.4.2. Inflammatory Diseases

7.4.3. Endocrine & Metabolic Disorders

7.4.4. Cancer

7.4.5. Other Diseases

Chapter 8. Global Human Microbiome Market, by Technology

8.1. Market Snapshot

8.2. Global Human Microbiome Market by Technology, Performance - Potential Analysis

8.3. Global Human Microbiome Market Estimates & Forecasts by Technology 2016-2026 (USD Million)

8.4. Human Microbiome Market, Sub Segment Analysis

8.4.1. Genomics

8.4.2. Proteomics

8.4.3. Metabolomics

Chapter 9. Global Human Microbiome Market, Regional Analysis

9.1. Human Microbiome Market, Regional Market Snapshot

9.2. North America Human Microbiome Market

9.2.1. U.S. Human Microbiome Market

9.2.1.1. Product breakdown estimates & forecasts, 2016-2026

9.2.1.2. Application breakdown estimates & forecasts, 2016-2026

9.2.1.3. Disease breakdown estimates & forecasts, 2016-2026

9.2.1.4. Technology breakdown estimates & forecasts, 2016-2026

9.2.2. Canada Human Microbiome Market

9.3. Europe Human Microbiome Market Snapshot

9.3.1. U.K. Human Microbiome Market

9.3.2. Rest of Europe Human Microbiome Market

9.4. Asia-Pacific Human Microbiome Market Snapshot

9.4.1. China Human Microbiome Market

9.4.2. India Human Microbiome Market

9.4.3. Japan Human Microbiome Market

9.4.4. Rest of Asia Pacific Human Microbiome Market

9.5. Latin America Human Microbiome Market Snapshot

9.5.1. Brazil Human Microbiome Market

9.5.2. Mexico Human Microbiome Market

9.6. Rest of The World Human Microbiome Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Enterome Bioscience

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Seres Therapeutics

10.2.3. 4D Pharma PLC

10.2.4. Ubiome, Inc.

10.2.5. E.I. Du Pont De Nemours and Company

10.2.6. Synlogic

10.2.7. Second Genome

10.2.8. Vedanta Biosciences, Inc.

10.2.9. Ferring Pharmaceuticals

10.2.10. Evelo Biosciences, Inc.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL HUMAN MICROBIOME MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL HUMAN MICROBIOME MARKET

TABLE 3. GLOBAL HUMAN MICROBIOME MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)

TABLE 7. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD MILLION)

TABLE 8. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)

TABLE 9. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY DISEASE 2016-2026 (USD MILLION)

TABLE 10. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD MILLION)

TABLE 11. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 12. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 13. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 14. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 15. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 16. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 17. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 18. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 19. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 20. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 21. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 22. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 23. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 24. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 25. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 26. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 27. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 28. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 29. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 30. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 31. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 32. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 33. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 34. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 35. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 36. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 37. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 38. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 39. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 40. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 41. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 42. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 43. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 44. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 45. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 46. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 47. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 48. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 49. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 50. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 51. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 52. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 53. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 54. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 55. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 56. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 57. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 58. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 59. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 60. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 61. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 62. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 63. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 64. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 65. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 66. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 67. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 68. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 69. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 70. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 71. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 72. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 73. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 74. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 75. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 76. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 77. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 78. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 79. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 80. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 81. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 82. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 83. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 84. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 85. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 86. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 87. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 88. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 89. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 90. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 91. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 92. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 93. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 94. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 95. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 96. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 97. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
View Details
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
View Details
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950
View Details
 
View More
 

Client Testimonials

2026 © Copyright Big Market Research